A Systematic Review of the Effectiveness of Antianxiety and Antidepressive Agents for Functional Dyspepsia

Objective Functional dyspepsia (FD) is defined as persistent or recurrent pain or discomfort centered in the upper abdomen without organic disease. Psychosocial factors have been proposed as an important element in the pathophysiology of FD. Therefore, psychotropic agents having antianxiety or antidepressive action are expected to alleviate FD. We previously reported on the treatment of FD using such agents in a systematic review, wherein the effectiveness of the agents on FD was suggested, although there were several limitations. We searched for articles on this subject after our systematic review and re-reviewed them systematically. Methods Articles were searched for in MEDLINE from 2003 to 2014 using terms related to antianxiety or antidepressive agents. Clinical studies in which the effectiveness of such agents was clearly stated were selected from the retrieved articles. The newly selected and previously selected studies were combined, and statistical analyses were carried out. Results Nine studies were selected. Five of the studies indicated a significant symptomatic improvement using psychotropic drugs. A statistical analysis suggested a significant treatment effect of psychotropic agents having antianxiety or antidepressive action [pooled relative risk (PRR), 0.72; 95% confidence interval (95% CI), 0.52-0.99; p=0.0406] but did not show a significant benefit of treatment with agents having an antidepressive action alone (PRR, 0.63; 95% CI, 0.38-1.03; p=0.0665). Conclusion Our systematic review suggested that psychotropic drugs having antianxiety and antidepressive actions as a whole might be effective in alleviating FD symptoms, whereas those having only antidepressive action were not effective.

[1]  P. Moayyedi,et al.  Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. , 2015, Gastroenterology.

[2]  A. Pariente,et al.  Why are benzodiazepines not yet controlled substances? , 2015, JAMA psychiatry.

[3]  K. Sugano,et al.  Evidence-based clinical practice guidelines for functional dyspepsia , 2015, Journal of Gastroenterology.

[4]  B. C. Wong,et al.  Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study. , 2012, World journal of gastroenterology.

[5]  J. Tack,et al.  Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  G. Boeckxstaens,et al.  Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double‐blind placebo‐controlled study , 2011, Alimentary pharmacology & therapeutics.

[7]  K. Tominaga,et al.  Efficacy of the 5-HT1A Agonist Tandospirone Citrate in Improving Symptoms of Patients With Functional Dyspepsia: A Randomized Controlled Trial , 2009, The American Journal of Gastroenterology.

[8]  P. Moayyedi,et al.  Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis , 2008, Gut.

[9]  R. Laheij,et al.  Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  D. Drossman,et al.  The functional gastrointestinal disorders and the Rome III process. , 1999, Gastroenterology.

[11]  T. Ohkusa,et al.  Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review , 2005, Journal of Gastroenterology.

[12]  M. Otaka,et al.  New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline , 2005, Alimentary pharmacology & therapeutics.

[13]  H. Seno,et al.  Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies , 2005, Alimentary pharmacology & therapeutics.

[14]  Y. Kinoshita,et al.  Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia , 2005, Alimentary pharmacology & therapeutics.

[15]  E. Deutsch Relief of anxiety and related emotions in patients with gastrointestinal disorders , 1971, The American Journal of Digestive Diseases.

[16]  F. Mearin,et al.  Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  H. Parkman,et al.  Effects of clonidine and tricyclic antidepressants on gastric smooth muscle contractility , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[18]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[19]  Chi-Sen Chang,et al.  Effect of fluoxetine on symptoms and gastric dysrhythmia in patients with functional dyspepsia. , 2003, Hepato-gastroenterology.

[20]  Y. Kinoshita,et al.  Prevalence of functional dyspepsia and its relationship with Helicobacter pylori infection in a Japanese population , 2001, Journal of gastroenterology and hepatology.

[21]  V. Savarino,et al.  Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis , 2000, Alimentary pharmacology & therapeutics.

[22]  S. Ishihara,et al.  Prevalence of non‐ulcer dyspepsia in the Japanese population , 1999, Journal of gastroenterology and hepatology.

[23]  J. Hyun,et al.  Effects of Levosulpiride in Patients with Functional Dyspepsia Accompanied by Delayed Gastric Emptying , 1998, The Korean journal of internal medicine.

[24]  K. Kroenke,et al.  Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome. , 1997, The American journal of medicine.

[25]  D. Quaglino,et al.  Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial. , 1996, The Italian journal of gastroenterology.

[26]  U. Malt,et al.  A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin. , 1996, Scandinavian journal of gastroenterology.

[27]  Y. Saitoh,et al.  Inhibitory effect of dopamine on gastric motility in rats. , 1995, Scandinavian journal of gastroenterology.

[28]  L. Arendt-Nielsen,et al.  The hypoalgesic effect of imipramine in different human experimental pain models , 1995, Pain.

[29]  G. Corazza,et al.  The eflects of levosulpiride on gastric and gall‐bladder emptying in functional dyspepsia , 1994, Alimentary pharmacology & therapeutics.

[30]  M. Zompo,et al.  A double‐blind study of L‐sulpiride versus amitriptyline in lithium‐maintained bipolar depressives , 1993, Acta psychiatrica Scandinavica.

[31]  L. Balart,et al.  Chlordiazepoxide-Clidinium Bromide in Gastrointestinal Disorders: Controlled Clinical Studies , 1968 .